We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Nintedanib (BIBF 1120) in Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01907100
Recruitment Status : Active, not recruiting
First Posted : July 24, 2013
Last Update Posted : March 13, 2018
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 16, 2018
  Estimated Study Completion Date : October 30, 2019